Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

KALA

KALA BIO (KALA)

KALA BIO Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KALA
DateTimeSourceHeadlineSymbolCompany
29/03/202423:00GlobeNewswire Inc.KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
04/03/202423:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
27/02/202400:00GlobeNewswire Inc.KALA BIO to Present at TD Cowen 44th Annual Healthcare ConferenceNASDAQ:KALAKALA BIO Inc
15/02/202405:09Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:KALAKALA BIO Inc
07/02/202400:00GlobeNewswire Inc.KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:KALAKALA BIO Inc
20/01/202408:01GlobeNewswire Inc.KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
06/01/202408:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
06/01/202408:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
06/01/202408:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
06/01/202408:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KALAKALA BIO Inc
23/12/202300:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
14/11/202300:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KALAKALA BIO Inc
14/11/202300:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
14/11/202300:00GlobeNewswire Inc.KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
19/10/202307:04Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:KALAKALA BIO Inc
21/09/202306:01GlobeNewswire Inc.KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
05/09/202322:00GlobeNewswire Inc.KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:KALAKALA BIO Inc
04/08/202322:00GlobeNewswire Inc.KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
03/08/202306:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:KALAKALA BIO Inc
03/08/202306:01GlobeNewswire Inc.KALA BIO to Participate in Upcoming Investor Conferences in AugustNASDAQ:KALAKALA BIO Inc
02/08/202322:00GlobeNewswire Inc.Kala Pharmaceuticals Announces Name Change to KALA BIONASDAQ:KALAKALA BIO Inc
20/07/202306:01GlobeNewswire Inc.Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
24/06/202306:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KALAKALA BIO Inc
24/06/202306:01GlobeNewswire Inc.Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:KALAKALA BIO Inc
23/06/202306:48Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:KALAKALA BIO Inc
16/06/202301:58Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:KALAKALA BIO Inc
02/06/202322:00GlobeNewswire Inc.Kala Pharmaceuticals to Present at the Jefferies Healthcare ConferenceNASDAQ:KALAKALA BIO Inc
01/06/202306:03Edgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)NASDAQ:KALAKALA BIO Inc
12/05/202307:26Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:KALAKALA BIO Inc
09/05/202322:00GlobeNewswire Inc.Kala Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:KALAKALA BIO Inc
 Showing the most relevant articles for your search:NASDAQ:KALA